Clinical Trial

Incidence of Bleeding, Thrombosis and Transfusion Requirements in ICU Patients With COVID-19 Supported With Veno-venous Extracorporeal Membrane Oxygenation

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 29, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The investigators aim to assess the risk of bleeding and thrombo-embolic complications as well as benefit and harm of blood product transfusion and anticoagulation therapy in adult ICU patients with COVID-19 supported with V-V ECMO
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-11.
Trial Details
NCT Number NCT07352072
Lead Sponsor Rigshospitalet, Denmark
Conditions VV ECMO, Bleeding, Thrombosis, Transfusion Adverse Reaction, COVID-19
Enrollment 50 participants
Start Date 2026-01
Primary Completion 2026-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-29